ICAM1 and hematocrit: Previous studies reported that HT reduced vascular inflammation, NF-κB activity, the expression of endothelial adhesion molecules (VCAM-1, ICAM-1 and E-selectin) and production of reactive oxygen species (ROS) [29,30,31].